Petri Bono

Researcher Next ID · RN-007528

Researcher · Medicine

Turku, Finland

Not currently recruitingFunding unknown

Research interests

Medicine

Immunology and Microbiology

Cancer Immunotherapy and Biomarkers

Renal cell carcinoma treatment

HER2/EGFR in Cancer Research

Immune cells in cancer

Cancer Treatment and Pharmacology

Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
The Lancet Oncology · 2016 · https://doi.org/10.1016/s1470-2045(16)30098-5
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1510665
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
Annals of Oncology · 2014 · https://doi.org/10.1093/annonc/mdu112
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
New England Journal of Medicine · 2006 · https://doi.org/10.1056/nejmoa053028

No projects listed.